In short. PRP and hair mesotherapy are two different injection methods, not two names for the same procedure. PRP works with your own plasma enriched with platelets and has the broader evidence base. Mesotherapy delivers a ready-made cocktail: vitamins, peptides, sometimes dutasteride or minoxidil. Both methods support hair that is still alive, and neither one brings back follicles that have died. The choice is dictated by the diagnosis and the stage, not by how popular a method is.
Patients often arrive with a ready-made request: ‘do PRP for me’. Or the opposite – ‘a friend had mesotherapy, I want the same’. The problem is that both procedures look identical: injections into the scalp, a course of several sessions, a promise of denser hair. From the outside there is no difference. Inside, the difference is fundamental.
Let us go through what exactly separates these methods, what the studies of the past two years show, in which situations a trichologist picks one rather than the other, and why ‘choose the best one’ is the wrong question to ask.
The fundamental difference between PRP and mesotherapy
PRP (platelet-rich plasma) is an autologous procedure. That means the material comes from you: blood from a vein, centrifugation, separation of the fraction with a high platelet concentration. The resulting plasma is injected into the scalp. What acts is not ‘vitamins’ but growth factors from your own platelets: PDGF, VEGF, IGF-1, TGF-β. We covered the mechanism in more detail in our article on PRP plasma therapy for hair.
Hair mesotherapy is the injection of an external preparation. The composition of the cocktail is set by the manufacturer or by the doctor: B vitamins, biotin, zinc, amino acids, peptides, hyaluronic acid. A separate and far more serious category is mesotherapy with active substances: dutasteride, minoxidil, bicalutamide, finasteride.
Hence the first practical difference. PRP is always the same in its logic and always different in its composition, because it depends on your blood. Mesotherapy is always different in its logic, because there are dozens of cocktails, and it is the composition that decides whether there will be any effect.
What this means for the patient
- PRP: the risk of an allergy is practically absent, because your own plasma is injected. It is not called completely zero either: the tube contains an anticoagulant, and some protocols use an activator. The result depends on the quality of the plasma preparation.
- Mesotherapy: the result is more predictable within one preparation, but the gap between preparations is wide. ‘Mesotherapy’ without a stated composition is neither a diagnosis nor a protocol.
What the research shows: where the evidence is stronger
Here the gap is substantial, and it is worth knowing before you pay for a course.
PRP in androgenetic alopecia has several meta-analyses of randomized trials. One of them (PubMed 39013743, 2024) gives a mean difference of about 27.5 hairs per cm² in favor of PRP compared with controls. That is a tangible gain. But the authors of the same meta-analysis state plainly that heterogeneity is high, that part of the work is of low quality, and that there are signs of publication bias. So the direction of the effect is confirmed, while its exact size is not.
Mesotherapy has a far weaker base. A systematic review of injectable modalities in androgenetic alopecia (PubMed 41603616) collected 30 papers, of which only 7 were interventional, 11 observational and 12 case reports. Multivitamin and peptide formulas were studied most often, then dutasteride, minoxidil, bicalutamide, growth factors and finasteride. The conclusion is cautious: a cosmetic benefit is possible, but the samples are small.
The single exception to this picture is mesotherapy with dutasteride. There is a separate meta-analysis of intradermal dutasteride (PMC12690437), which shows an advantage over placebo in hair count, in the assessment of independent observers and in patient self-assessment. That is logical: dutasteride has its own proven mechanism, so the injection only changes the delivery route of a drug that already works.
Direct comparison: what the studies that set the methods side by side say
Direct comparisons are scarce, and the most interesting of the recent papers is a retrospective study in Skin Appendage Disorders (2024, volume 10, pp. 376–382, PubMed 39386300). 72 patients with androgenetic alopecia, two different PRP formulas and two different mesotherapy preparations with recombinant growth factors and stem cell conditioned medium. Trichoscopic parameters of the frontal zone and the crown were measured before treatment and after 6 months.
The result deserves a careful read. Both groups, PRP and mesotherapy, produced a statistically significant improvement in most parameters. However, the difference in hair thickness change between the two PRP formulations was also statistically significant (p<0.001). In other words, the choice of a specific product within a single method affects the outcome, and that effect should not be dismissed.
The practical conclusion is this: the question of PRP versus mesotherapy is not the only thing that determines the result. Which specific formulation is used, and who prepares it, matters just as much. That is an awkward answer for anyone who wants a simple ranking, but it is the answer the data supports.
When a trichologist is more likely to choose PRP
PRP is the more logical option in these situations:
- Early and moderate stage of androgenetic alopecia: the follicles are miniaturized but alive. This is where PRP has the most data.
- Support alongside base therapy: the patient already takes finasteride or applies minoxidil, and an extra stimulus is needed.
- Contraindications to systemic agents: when finasteride or dutasteride are not suitable for health reasons, and the patient does not want foreign substances injected into the scalp.
- The period before and after a transplant: PRP is used as an adjunct to transplantation, to support the native hair in the surgical area.
- Slow density recovery: when baseline therapy has already stabilized shedding, but density in the frontal area returns too slowly.
When mesotherapy is the more logical choice
Mesotherapy wins when a specific substance is needed in a specific place:
- A local antiandrogen is needed: mesotherapy with dutasteride makes it possible to act on the scalp while reducing systemic exposure. That is an argument for patients who tolerate tablets poorly.
- Local delivery of minoxidil: when topical minoxidil irritates the skin, or the person cannot keep to a daily routine.
- Deficiency states as an adjunct: with a confirmed deficiency, injection support sometimes adds to oral correction. To be clear: it adds to, it does not replace tests and treatment of the cause.
- Fear of a blood draw: a mundane but real reason why some patients turn down PRP.
A separate word on telogen (diffuse) alopecia. Injections are not the first line here at all. Diffuse shedding has a cause: iron, the thyroid gland, a recent illness, stress, rapid weight loss. Until the cause is found and corrected, any course of injections is an expensive way to postpone the diagnosis.
Protocol and timing: what to expect realistically
Both methods run as a course, and that is the main thing to take in before the first session.
For PRP the most common schedule is 3–5 sessions about a month apart, then maintenance roughly every 6 months. Volume 5–7 ml of plasma, injection of 0.05–0.1 ml per cm² with a step of about 1 cm, depth 2–4 mm. There is no consensus on platelet concentration: different sources cite a target of 2–6 times above baseline, while the best reported outcomes fall in the narrower range of 1.5–5 times. These come from different studies, not from one agreed standard. ISHRS openly admits that concentration, activation method, depth and injection frequency differ from clinic to clinic, so comparing ‘PRP here’ with ‘PRP there’ is not valid.
Mesotherapy usually runs a denser course: 8–10 sessions once a week or once every two weeks, then maintenance. The exact schedule depends on the preparation, and the interval should be set by the manufacturer’s instructions, not by a clinic habit.
Assessment timing is the same for both. The first changes on trichoscopy appear after 3 months, a visually noticeable difference closer to 6 months. Judging the result earlier makes no sense: the hair cycle simply has no time to respond.
Safety, side effects and honest limits
Both procedures are minimally invasive, but not ‘zero risk’.
Typical reactions after a session: pain during the injections, swelling, redness, pinpoint bruising, skin sensitivity for 1–2 days. This is expected and settles on its own.
The risks specific to mesotherapy are more serious precisely because an external preparation is involved. Systematic reviews describe paradoxical alopecia, scarring and acute dermatitis among the adverse events. The frequency is low, but these complications are real, and they depend directly on the cocktail composition and on sterility.
For PRP the main limits are different: clotting disorders, thrombocytopenia, anticoagulant therapy, active scalp infection, oncological and systemic disease in an active phase. Every one of these points is discussed at the consultation, not on the couch.
Comparison by criteria
| Criterion | PRP plasma therapy | Mesotherapy |
|---|---|---|
| What is injected | Your own plasma enriched with platelets | A ready-made preparation: vitamins, peptides or an active substance |
| Source of the effect | Your own growth factors (PDGF, VEGF, IGF-1, TGF-β) | The cocktail composition |
| Evidence base in androgenetic alopecia | Meta-analyses of RCTs; in one of them the mean difference was about 27.5 hairs per cm² versus control | Mostly small and observational studies; dutasteride has a separately stronger base |
| Typical course | 3–5 sessions once a month | 8–10 sessions once every 1–2 weeks |
| Maintenance | Roughly every 6 months | Depends on the preparation |
| Allergy risk | Practically absent | Present, depends on the composition |
| Main limitation | Blood and clotting status | Quality and composition of the preparation |
| First changes | 3 months, assessment at 6 | 3 months, assessment at 6 |
Can they be combined, and where to start
Combining them is practiced, and there is logic to it: PRP gives a stimulus through your own growth factors, while mesotherapy with dutasteride works against the miniaturization mechanism. Formally they do not conflict. But controlled studies of the combination are few, so promising a ‘double effect’ is not correct.
A smarter order looks like this. Diagnosis first: trichoscopy, history, tests if needed. Then base therapy with proven efficacy, if it is indicated. And only after that an injection method as an additional tool, not as a substitute for treatment.
The typical mistake looks like this: a person goes through a course of 10 sessions, spends money and six months of time, while miniaturization progresses, because nobody stopped the androgen mechanism. The problem is not the injections themselves, but the fact that they became the first step instead of the second.
Frequently asked questions
Which is more effective: PRP or mesotherapy?+
There is no correct answer of the ‘one is more effective’ kind. PRP has the stronger evidence base in androgenetic alopecia: in one of the meta-analyses of randomized trials the mean difference was about 27.5 hairs per cm² versus control. Mesotherapy rests mostly on small and observational studies, except for mesotherapy with dutasteride, which has its own meta-analysis. At the same time, a direct 2024 comparison showed that the outcome also depends noticeably on the specific product used within each method. So the choice is dictated by the diagnosis and the composition of the preparation, not by the name of the method.
How many sessions are needed, and when will the result be visible?+
For PRP the typical schedule is 3–5 sessions about a month apart, then maintenance roughly every 6 months. Mesotherapy usually runs denser: 8–10 sessions once every one to two weeks. Assessment timing is the same: the first changes are visible on trichoscopy after 3 months, a visually noticeable difference closer to 6 months. Judging earlier makes no sense, because the hair cycle has no time to respond.
Can PRP and mesotherapy be done at the same time?+
Combining them is practiced, and in theory the methods do not conflict: PRP stimulates through your own growth factors, while mesotherapy with dutasteride acts against the miniaturization mechanism. But controlled studies of the combination are few, so promising a double effect is not correct. A smarter order is diagnosis and base therapy first, and only then an injection method as an additional tool.
Will injections help if the bald patch is already completely smooth?+
No. Neither method revives a follicle that is already gone. If the skin in the bald area is smooth and shiny and trichoscopy does not see even thin hairs, injections will not produce growth. Such a zone is a question of hair transplantation. Injection methods work where the follicles are miniaturized but alive.
What side effects are possible after these procedures?+
The typical reactions are the same: pain during the injections, swelling, redness, pinpoint bruising, skin sensitivity for one to two days. For mesotherapy, systematic reviews describe more serious though rare complications: paradoxical alopecia, scarring, acute dermatitis. They depend on the cocktail composition and on sterility. For PRP the main limits are different: clotting disorders, thrombocytopenia, anticoagulants, active scalp infection.
Why is mesotherapy with dutasteride different from the vitamin version?+
Because these are procedures of different evidence classes. Vitamin and peptide cocktails rest on small and mostly observational studies. Dutasteride has its own proven mechanism, so the injection only changes the delivery route of a drug that already works: the meta-analysis of intradermal dutasteride shows an advantage over placebo in hair count and in patient assessment. That is why the cocktail composition is worth clarifying before the first session.
Do injections replace finasteride and minoxidil?+
No, they do not replace them. In androgenetic alopecia, base therapy works against the miniaturization mechanism itself, while injection methods add a stimulus. The typical mistake is to go through a course of ten sessions while nobody has stopped the androgen process. The problem is not the injections themselves, but the fact that they became the first step instead of the second.